Transgene Biotek Ltd vs Unihealth Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Transgene Biotek Ltd is ₹ 2.33 as of 30 Oct 15:30 . The P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Unihealth Hospitals Ltd changed from 20.2 on March 2024 to 22 on March 2026 . This represents a CAGR of 2.89% over 3 years The Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Unihealth Hospitals Ltd changed from ₹ 207.9 crore on March 2024 to ₹ 568.97 crore on March 2026 . This represents a CAGR of 39.88% over 3 years The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The revenue of Unihealth Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The ebitda of Unihealth Hospitals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Unihealth Hospitals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Unihealth Hospitals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

About Unihealth Hospitals Ltd

Unihealth Consultancy Limited was incorporated as Private Limited Company under the name 'Unihealth Consultancy Private Limited', Certificate of Incorporation was issued by the Registrar of Companies, Mumbai on February 26, 2010.
The Company status changed to Public Limited, and its name was changed to 'Unihealth Consultancy Limited' dated April 26, 2023 issued by the Registrar of Companies, Mumbai. Unihealth Consultancy Limited is the Holding Company of the Group providing healthcare consultancy and management services.
The Company facilitates medical value travel for patients travelling from various countries into Middle East and Africa to India for advanced medical care services.
The Company is a healthcare service provider based out of Mumbai, India having operational presence in multiple countries across the African continent.

FAQs for the comparison of Transgene Biotek Ltd and Unihealth Hospitals Ltd

Which company has a larger market capitalization, Transgene Biotek Ltd or Unihealth Hospitals Ltd?

Market cap of Transgene Biotek Ltd is 17 Cr while Market cap of Unihealth Hospitals Ltd is 874 Cr

What are the key factors driving the stock performance of Transgene Biotek Ltd and Unihealth Hospitals Ltd?

The stock performance of Transgene Biotek Ltd and Unihealth Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Transgene Biotek Ltd and Unihealth Hospitals Ltd?

As of October 31, 2026, the Transgene Biotek Ltd stock price is INR ₹2.33. On the other hand, Unihealth Hospitals Ltd stock price is INR ₹550.25.

How do dividend payouts of Transgene Biotek Ltd and Unihealth Hospitals Ltd compare?

To compare the dividend payouts of Transgene Biotek Ltd and Unihealth Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.